Israel News Beep | NewsBeep.com
  • News Beep
  • Israel
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
Israel News Beep | NewsBeep.com
Israel News Beep | NewsBeep.com
  • News Beep
  • Israel
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

Pharmaceutical Sciences/Technology

5 posts
HHealth
Trends in childhood visual impairment. Insights from a 10-year retrospective study at Alder Hey Children’s Hospital
Read More

Trends in childhood visual impairment. Insights from a 10-year retrospective study at Alder Hey Children’s Hospital

  • May 23, 2026
Purpose To describe trends in childhood certificate of visual impairment (CVI) registrations over a 10-year period (2010–2019) at…
HHealth
Racial and microvascular determinants of progression to treatment-warranted diabetic eye disease
Read More

Racial and microvascular determinants of progression to treatment-warranted diabetic eye disease

  • April 7, 2026
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major…
SScience
Vector analysis of a toric refractive multifocal IOL with continuous transitional focus technology: rotational and refractive outcomes, a pilot evaluation
Read More

Vector analysis of a toric refractive multifocal IOL with continuous transitional focus technology: rotational and refractive outcomes, a pilot evaluation

  • April 1, 2026
Authors and Affiliations Vissum, Grupo Miranza, Alicante, Spain Ronald Steven S. Medalle II, Antonio Martínez-Abad & Jorge L. Alió Cornea and…
SScience
Sildenafil use and risk of serous retinal detachment in men with erectile dysfunction in US
Read More

Sildenafil use and risk of serous retinal detachment in men with erectile dysfunction in US

  • February 21, 2026
Phosphodiesterase type 5 inhibitors (PDE5i) are widely used for erectile dysfunction. Case reports and claims-based cohort studies have…
BBusiness
SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degeneration
Read More

SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degeneration

  • January 30, 2026
Competing interests CB: Honoraria from Alimera Sciences, Apellis, Bayer, and Roche; and has served on advisory boards for…
Israel News Beep | NewsBeep.com
www.newsbeep.com